Christopher Parham, M.D.
Department of Plastic Surgery, Division of Surgery
Present Title & Affiliation
Primary Appointment
Assistant Professor, Department of Plastic Surgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
2015 | McGovern Medical School at The University of Texas Health Science Center, Houston, TX, USA, MD, Medicine |
Selected Publications
Peer-Reviewed Articles
- McLaughlin C, Hughes AJ, Parham CS, Fritsche M, Potochny JD, Kunselman A, Ravnic DJ. Smooth Versus Textured Tissue Expander Breast Reconstruction: Complications and Efficacy. Ann Plast Surg 88(3 Suppl 3):S288-S292, 2022. PMID: 35513333.
- Parham CS, Hanson SE, Butler CE, Calobrace MB, Hollrah R, Macgregor T, Clemens MW. Advising patients about breast implant associated anaplastic large cell lymphoma. Gland Surg 10(1):417-429, 2021. PMID: 33634000.
- Parham CS, Shen C, Pennock MM, Henderson SR, Kulaylat AS, Johnson TS. Correlation between Venous Thromboembolism Risk and Venous Congestion in Microvascular Reconstruction of the Lower Extremity. Plast Reconstr Surg 146(5):1177-1185, 2020. PMID: 33136965.
- Ibrahim AE, Skoracki R, Goverman JG, Sarhane KA, Parham CS, Abu-Sittah G, Kaddoura I, Atiyeh BS. Microsurgery in the burn population - a review of the literature. Ann Burns Fire Disasters 28(1):39-45, 2015. PMID: 26668561.
- Desai SS, DuBose JJ, Parham CS, Charlton-Ouw KM, Valdes J, Estrera AL, Safi HJ, Azizzadeh A. Outcomes after endovascular repair of arterial trauma. J Vasc Surg 60(5):1309-1314, 2014. e-Pub 2014. PMID: 24997806.
- Grover GJ, Burkett DE, Parham CS, Scalese RJ, Sadanaga KK. Protective effect of mitochondrial KATP activation in an isolated gracilis model of ischemia and reperfusion in dogs. J Cardiovasc Pharmacol 42(6):790-2, 2003. PMID: 14639102.
- Grover GJ, D'Alonzo AJ, Darbenzio RB, Parham CS, Hess TA, Bathala MS. In vivo characterization of the mitochondrial selective K(ATP) opener (3R)-trans-4-((4-chlorophenyl)-N-(1H-imidazol-2-ylmethyl)dimethyl-2H-1-benzopyran-6-carbonitril monohydrochloride (BMS-191095): cardioprotective, hemodynamic, and electrophysiological effects. J Pharmacol Exp Ther 303(1):132-40, 2002. PMID: 12235243.
- Grover GJ, D'Alonzo AJ, Dzwonczyk S, Parham CS, Darbenzio RB. Preconditioning is not abolished by the delayed rectifier K+ blocker dofetilide. Am J Physiol 271(3 Pt 2):H1207-14, 1996. PMID: 8853361.
- Grover GJ, Parham CS, Whigan DB, Mitroka JG. BMS-180448, a novel glyburide-reversible cardioprotective agent, enhances postischemic recovery of contractile function in dogs. J Pharmacol Exp Ther 276(2):380-7, 1996. PMID: 8632300.
- Grover GJ, Dzwonczyk S, McMullen DM, Normandin DE, Parham CS, Sleph PG, Moreland S. Pharmacologic profile of the dihydropyrimidine calcium channel blockers SQ 32,547 and SQ 32,926 [correction of SQ 32,946]. J Cardiovasc Pharmacol 26(2):289-94, 1995. PMID: 7475054.
- Grover GJ, D'Alonzo AJ, Parham CS, Darbenzio RB. Cardioprotection with the KATP opener cromakalim is not correlated with ischemic myocardial action potential duration. J Cardiovasc Pharmacol 26(1):145-52, 1995. PMID: 7564356.
- Grover GJ, Parham CS, Youssef S, Ogletree ML. Protective effect of the serotonin receptor antagonist cinanserin in two canine models of pacing-induced myocardial ischemia. Pharmacology 50(5):286-97, 1995. PMID: 7667390.
- Grover GJ, Dzwonczyk S, Parham CS. The endothelin-1 receptor antagonist BQ-123 reduces infarct size in a canine model of coronary occlusion and reperfusion. Cardiovasc Res 27(9):1613-8, 1993. PMID: 8287438.
- D'Alonzo AJ, Darbenzio RB, Parham CS, Grover GJ. Effects of intracoronary cromakalim on postischaemic contractile function and action potential duration. Cardiovasc Res 26(11):1046-53, 1992. PMID: 1291081.
- Grover GJ, Parham CS, Schumacher WA. The combined antiischemic effects of the thromboxane receptor antagonist SQ 30,741 and tissue-type plasminogen activator. Am Heart J 121(2 Pt 1):426-33, 1991. PMID: 1825008.
- Grover GJ, Parham CS, Schumacher WA. The cardioprotective effects of the thromboxane receptor antagonist SQ 30,741 are not reversed by aspirin. Basic Res Cardiol 86(2):99-106, 1991. PMID: 1831610.
- Grover GJ, Sleph PG, Parham CS, Brittain RJ, Krapcho J, Moreland S. Anti-ischemic activity of the novel benzazepine calcium antagonist SQ 31,486. J Cardiovasc Pharmacol 16(2):219-27, 1990. PMID: 1697377.
- Grover GJ, Sleph PG, Parham CS. Nicorandil improves postischemic contractile function independently of direct myocardial effects. J Cardiovasc Pharmacol 15(5):698-705, 1990. PMID: 1692928.
- Grover GJ, Dzwonczyk S, Parham CS, Sleph PG. The protective effects of cromakalim and pinacidil on reperfusion function and infarct size in isolated perfused rat hearts and anesthetized dogs. Cardiovasc Drugs Ther 4(2):465-74, 1990. PMID: 2285630.
- Grover GJ, Parham CS, Sleph PG, Moreland S. Anti-ischemic and vasorelaxant effects of the new benzazepine calcium channel blocker SQ 31,765. J Pharmacol Exp Ther 251(3):1020-5, 1989. PMID: 2481028.
- Grover GJ, Parham CS. Role of thromboxane A2 in the control of myocardial O2 supply/consumption balance and severity of ischemia during pacing-induced ischemia. Circ Res 64(3):575-82, 1989. PMID: 2917381.
- Grover GJ, Sleph PG, Parham CS. Effect of diltiazem on infarct size, reperfusion flow and flow reserve: the effect of timing of treatment. J Pharmacol Exp Ther 246(1):263-9, 1988. PMID: 3392657.
- Grover GJ, Parham CS. Effect of intracoronary diltiazem on ST-segment elevation and myocardial blood flow during pacing-induced ischemia. J Cardiovasc Pharmacol 10(5):548-54, 1987. PMID: 2447404.
- Grover GJ, Parham CS. The effect of diltiazem on ST-segment elevation and myocardial blood flow distribution during pacing-induced ischemia. Eur J Pharmacol 143(1):109-17, 1987. PMID: 3691645.
- Saini RK, Fulmor IE, Parham CS, Antonaccio MJ. Effects of SQ 26,533 on reperfusion arrhythmias, ST-segment elevation and on infarct size in anesthetized dogs. J Pharmacol Exp Ther 237(1):1-8, 1986. PMID: 3958960.
- Evans DB, Parham CS, Laffan RJ. Non-specific myocardial depression by beta-adrenergic receptor blockers in normal and compromised myocardium. Arch Int Pharmacodyn Ther 240(2):240-8, 1979. PMID: 41496.
- Evans DB, Parham CS, Schenck MT, Laffan RJ. Stimulation of myocardial contractility by a new cyclic nucleotide analog, 8-(benzylthio)-N6-n-butyladenosine cyclic 3',5'-phosphate (SQ 80122). J Cyclic Nucleotide Res 2(4):307-19, 1976. PMID: 184129.
Patient Reviews
CV information above last modified December 28, 2022